| abstract |
The present invention provides compounds of formula (I) below, or optical isomers, diastereomers or enantiomers thereof, or pharmaceutically acceptable salts thereof, or biohydrolysis thereof, useful as inhibitors of metalloproteases as described in the claims Possible amides, esters, or imides are provided. Also described are pharmaceutical compositions and methods for treating diseases, disorders and conditions characterized by metalloprotease activity using these compounds or pharmaceutical compositions containing them. |